ArticleExperimental and therapeutic medicine2019

miR-628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway.

Jun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.